Back
Arcus Biosciences 10K Form
Sell
29
RCUS
Arcus Biosciences
Last Price:
20.47
Seasonality Move:
48.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCUS News And Ratings
See the #1 stock for the next 7 days that we like better than RCUS
RCUS Financial Statistics
Sales & Book Value
Annual Sales: | $382.88M |
---|---|
Cash Flow: | $-82.28M |
Price / Cash Flow: | 3.66 |
Annual Sales: | $9.68 |
Price / Book: | 2.12 |
Profitability
EPS (TTM): | 0.92000 |
---|---|
Net Income (TTM): | $79.82M |
Gross Margin: | -- |
Return on Equity: | 11.01% |
Return on Assets: | 5.83% |
Arcus Biosciences Earnings Forecast
Key Arcus Biosciences Financial Ratios
- The Research & Development expenses have been 66.95% of Revenue.
- The Interest Expense is 0.49% of Operating Income.
- The Net Earning history of RCUS is 13.80% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Arcus Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | RCUS |
CUSIP: | 03969F |
Website: | arcusbio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.21 |
Quick Ratio: | 6.09 |
Price-to-Earnings
Trailing P/E Ratio: | 28.89 |
---|---|
Forward P/E Ratio: | 0 |
RCUS Technical Analysis vs Fundamental Analysis
Sell
29
Arcus Biosciences (RCUS)
is a Sell
Is Arcus Biosciences a Buy or a Sell?
-
Arcus Biosciences stock is rated a Sell
The current Arcus Biosciences [RCUS] share price is $20.51. The Score for RCUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.